(Q42144925)

17 October 2017

Clarification of Bladder Cancer Disease States Following Treatment of Patients with Intravesical BCG. (English)

1 reference

17 October 2017

1 reference

Seth P Lerner

1

1 reference

17 October 2017

Colin Dinney

2

1 reference

17 October 2017

Ashish Kamat

3

1 reference

17 October 2017

Trinity J Bivalacqua

4

1 reference

17 October 2017

Matthew Nielsen

5

1 reference

17 October 2017

Michael O'Donnell

6

1 reference

17 October 2017

Mark P Schoenberg

7

1 reference

17 October 2017

Gary Steinberg

8

1 reference

17 October 2017

1 March 2015

1 reference

Bladder Cancer (Amsterdam, Netherlands)

17 October 2017

1 reference

17 October 2017

1

1 reference

17 October 2017

29-30

1 reference

17 October 2017

1

1 reference

Creative Commons Attribution-NonCommercial 4.0 International

17 October 2017

start time

30 April 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Defining progression in nonmuscle invasive bladder cancer: it is time for a new, standard definition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4720147

PubMed Central

reference URL

Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4720147

PubMed Central

reference URL

17 August 2018

Identifiers

0 references

1 reference

17 October 2017

1 reference